Refine by
Industries served
- Medical / Health Care
- Air and Climate
- Chemical & Pharmaceuticals
- Agriculture
- Monitoring and Testing
- Health and Safety
- Manufacturing, Other
- Food and Beverage
- Mining
- Defense
- Waste and Recycling
- Water and Wastewater
- Environmental
- University / Academia / Research
- Energy
- Construction & Construction Materials
- Automobile & Ground Transport
- Electronics and Computers
- Aerospace & Air Transport
- Communications / Telecom / Datacom
- Oil, Gas & Refineries
- Soil and Groundwater
- Government
Cell Therapy For All Stem Cell Suppliers Near Mexico
181 companies found
Premium
based inMontigny-le-Bretonneux, FRANCE
Bertin Technologies is a French industrialist in scientific instrumentation that designs and manufactures, in France and in Europe, measurement, observation & detection systems and instruments for critical applications. Every day, Bertin ...
based inPessac, FRANCE
We bring together biophysicists, stem cell biologists & bioproduction engineers around the motto 'Cell Therapy for All'. TreeFrog Therapeutics was created to provide access to safe, efficient and affordable cell therapies for millions of patients. ...
C-Stem™ is a biomimetic cell culture technology allowing for the mass-production of stem cell- derived therapies with unprecedented cell quality, while cutting manufacturing costs by 10x. ...
based inNew York, NEW YORK (USA)
Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies ...
TARA-002 is an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). TARA-002 was developed from the same master cell bank of genetically distinct group A ...
based inCambridge, MASSACHUSETTS (USA)
Obsidian Therapeutics is using its proprietary cytoDRiVE platform to harness the power of proteins to engineer precision medicines. Our lead internal programs are focused on engineering TIL therapies that are more effective and safer for patients ...
Engineered with membrane-bound IL15, Eliminates toxic IL2 regimen, increasing patient accessibility to TIL therapy, Drives improved persistence, IL15 expression controlled by acetazolamide (ACZ), via cytoDRiVE® ...
based inCambridge, UNITED KINGDOM
Atelerix was spun out of Newcastle University (UK) in June 2017 by the three co-founders, Professor Che Connon, Dr Steve Swioklo and Dr Mick McLean. The company is commercializing the gel encapsulation approach in two main sectors: Cell models used ...
based inCambridge, MASSACHUSETTS (USA)
Vericel manufactures advanced cell therapies for the sports medicine and severe burn care markets. The goal of our therapies is to repair or restore a patient's damaged tissues or organs using their own cells. Please use the links to the right to ...
based inKoln, GERMANY
IMPACT International GmbH was founded in 2018 to facilitate the international sales of IMPACT Platform for Autologous Cell Therapies and to serve distribution partners across the world. IMPACT Platform for Autologous Cell Therapies is the ...
Autologous cell therapies make use of the natural endogenous mechanisms for the regeneration and healing of injured tissue. The body’s response to an injury is a complex healing cascade in order to heal the wound as quickly as possible. To ...
based inSan Diego, CALIFORNIA (USA)
Resilience is your biomanufacturing innovation partner, leading the pursuit of novel medicines by revolutionizing how they’re made, funded and scaled. The technology of manufacturing complex medicines, like cell and gene therapies, hasn’t kept pace ...
Innovators in immunotherapy, stem cell therapy, and regenerative medicine will find like-minded champions at ...
based inParis, FRANCE
We are a biotech company combining microfluidics, digitalization and bioengineering to make high quality biological therapies at affordable cost and minimized environmental impact. Therapeutic cells can multiply in the patient's body. This allows ...
In healthy patients T cells detect and kill sick cells. Cancer cells escape T cells recognition thanks to mutations. CAR-T cells (T cells equipped with a Chimeric Antigen Receptor) are artificially hardcoded to recognize and kill cancer cells. ...
based inTokyo, JAPAN
We create plug-and-play bio-manufacturing solutions using our unique cell culture platform technology, CellFiber™, to enable higher yields and product quality and ensure stability, predictability, reproducibility, and scalability of cells for cell ...
based inBuffalo, NEW YORK (USA)
Tactiva Therapeutics is an immuno-oncology company specializing in potent cancer immunotherapy using a dual T cell receptor ...
Adoptive Cell Transfer (ACT) is a form of immunotherapy that targets tumors specifically and potently by utilizing large numbers of a patient’s own immune cells to target and destroy cancer cells. Typically, starting with a few ...
based inTampa, FLORIDA (USA)
Saneron is a biotechnology R&D company, focused on neurological and cardiac cell therapy for the early intervention and treatment of several devastating or deadly diseases, which lack adequate treatment options. Saneron, a University of South ...
The SERT-CELL program explores the unique potential of Sertoli cells, protein-rich cells found in the mammalian testes, which inhibit immune reactions to foreign tissues, including transplants. Sertoli cells provide localized immunosuppression, ...
based inAllendale, NEW JERSEY (USA)
We are a leading global contract development and manufacturing organization (CDMO) dedicated to the advancement and manufacturing of gene and cell therapy products. Minaris Regenerative Medicine is a leading global contract development and ...
At Minaris Regenerative Medicine, we are committed to bringing together and further developing highly talented, skilled, and dedicated experts with varied backgrounds applicable to gene and cell therapy manufacturing and development. Having this ...
based inJerusalem, ISRAEL
Betalin Therapeutics licensed the novel Engineered Micro Pancreas (EMP) technology developed at The Hebrew University of Jerusalem, Israel, in an exclusive worldwide agreement in 2015. The Hebrew University continues to partner with Betalin ...
Islet transplantation is a widely used cell therapy technique which achieves normoglycemia (normal blood glucose levels) in diabetic patients. However, one of the biggest challenges is early islet cell death, this tends to occur before the ...
based inTokyo, JAPAN
Healios will expand the possibilities for curing diseases to increase and further enrich quality of life through the development and supply of regenerative medicine products as part of the rapid progress of regenerative medicine taking place in the ...
Induced pluripotent stem cells (iPSCs) are established by introducing several factors to somatic cells such as skin cells. iPSCs can differentiate into the cells of a various tissues or organs (pluripotency) and grow indefinitely (proliferation). ...
based inStratford-upon-Avon, UNITED KINGDOM
Our team of world-class scientists and biotechnology leadership is devoted to discovering breakthrough medicines that change the standard of medical care for patients. Sir Martin Evans, Nobel Laureate, and Ajan Reginald, former Global Head of ...
PHASE 3 : Our investigational topical gel containing platelet lysate is capable of regenerating injured tendons near the surface of the ...
based inViken, SWEDEN
TIKOMED AB is a privately owned company based in Viken, Sweden. It is governed by the Laws of the Kingdom of Sweden and was formed in accordance with the Swedish Company Act in 2002. We develop and commercialize innovative treatments for patients ...
Cell therapies are associated with graft loss. It involves activation of the complement and coagulation cascades when cells come into contact with blood, ultimately resulting in cell death. IBSOLVMIR is an infusion product that inhibits IBMIR and ...
based inCambridge, UNITED KINGDOM
Founded by Dr Mark Kotter and Florian Schuster, bit.bio is an award-winning human synthetic biology enterprise. bit.bio™s mission is coding cells for health. To do so, we apply the principles of computation to biology. Our current focus is to ...
opti-ox™ is capable of producing batches of every cell in the human body at scale and gives us the power to precision engineer human cells. This is because it reliably activates specific transcription factors within the cells. Transcription ...
based inCarlsbad, CALIFORNIA (USA)
Our mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions. Lineage’s programs are based on the Company’s proprietary cell-based therapy platform and associated ...
VAC2 is an allogeneic, or non-patient specific, cancer vaccine candidate designed to stimulate patient immune responses to telomerase which is commonly expressed in cancerous cells but not in normal adult cells. VAC2, which is produced from our ...
based inFlorham Park, NEW JERSEY (USA)
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and ...
CYNK-001 is the only cryopreserved, allogeneic, off-the-shelf, natural killer (NK) cell therapy being developed from placental hematopoietic stem cells as a potential treatment option for various hematologic cancers, solid tumors, and infectious ...